[Tamoxifen; wider indications, more frequent controls?].
Rutgers
E J
EJ
Nortier
J W
JW
Beex
I
I
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009426:Netherlands; D010048:Ovarian Cysts / Q000139:chemically induced / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D017697:Premenopause; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen